Market Movers | Winners: PACB, MNKD, CTNM | Losers: LQDA, GLAS, QNC

SPYYTD+12.4%SPYYTD+12.4%QQQYTD+20.7%
Analyze SPY →

On Wednesday, September 30, the S&P 500 declined 0.3%, the Nasdaq-100 edged up 0.2% and the Dow Jones Industrial Average slipped 0.9%. Over the past week the S&P 500 is down 0.7%, and over the past month it is down 0.5%.

Within the Trefis coverage universe, 1,373 stocks rose and 2,712 fell. Pacific Biosciences of California (PACB) gained 29.5% to lead the day, while Liquidia (LQDA) fell 57.2%, the weakest showing.

Photo by ArtsyBee on Pixabay

 
Wednesday’s Market Winners

The 10 US-listed stocks in the Trefis coverage universe worth at least $300 million with the highest returns on Wednesday:
 

# Ticker Company Name 1-D
Returns
YTD
Returns
1 PACB Pacific Biosciences of California 29.5% 26.7%
2 MNKD MannKind 16.8% -31.2%
3 CTNM Contineum Therapeutics 16.7% 17.4%
4 UTHR United Therapeutics 12.5% 11.2%
5 CDNL Cardinal Infrastructure 11.8% 26.6%
6 OPTX Syntec Optics 11.3% 188.5%
7 ROG Rogers 10.7% 67.1%
8 CAPR Capricor Therapeutics 10.5% n/a
9 CBNK Capital Bancorp 10.3% 41.1%
10 FORM FormFactor 9.6% 167.7%

 
Wednesday’s Market Losers

And the 10 US-listed stocks in the Trefis coverage universe worth at least $300 million with the lowest returns on Wednesday:
 

# Ticker Company Name 1-D
Returns
YTD
Returns
1 LQDA Liquidia -57.2% -12.3%
2 GLAS Glass House Brands -17.4% n/a
3 QNC Quantum eMotion -15.4% n/a
4 ETON Eton Pharmaceuticals -13.0% 204.5%
5 BXBL BOXABL -12.6% n/a
6 STC Stewart Information Services -12.4% -27.5%
7 EMAT Evolution Metals & Technologies -12.4% n/a
8 TRLV Trulieve Cannabis -12.2% n/a
9 ADV Advantage Solutions -12.1% n/a
10 JBL Jabil -10.0% 25.9%

For A Few Names, Wednesday Extended A Monthly Trend

The 29.5% gain in Pacific Biosciences of California (PACB) on Wednesday was not a one-off: the stock is up 74.9% over the past month, and up 35.1% over the sessions before Wednesday.

Liquidia (LQDA) is also on the one-month losers list (down 55.6%), but that move came almost entirely from Wednesday: over the rest of the month the stock was up 3.7%.

Movers Over The Last Week

Widening the window to five trading days, these are the strongest and weakest names in the Trefis coverage universe:
 
Winners
 

# Ticker Company Name 1-W
Returns
YTD
Returns
1 PACB Pacific Biosciences of California 68.1% 26.7%
2 DNA Ginkgo Bioworks 49.5% 54.4%
3 IOVA Iovance Biotherapeutics 45.4% 442.9%
4 FBYD Falcons Beyond Global 26.5% -43.7%
5 TWST Twist Bioscience 21.9% 509.2%
6 PWP Perella Weinberg Partners 21.8% -4.6%
7 MNTK Montauk Renewables 20.0% 63.5%
8 CDNA CareDx 19.7% 245.0%
9 TXG 10x Genomics 19.5% 454.0%
10 P Everpure 19.3% n/a

 
Losers
 

# Ticker Company Name 1-W
Returns
YTD
Returns
1 LQDA Liquidia -55.2% -12.3%
2 QURE uniQure -43.5% 1.0%
3 KDK Kodiak AI -35.4% -82.4%
4 FICO Fair Isaac -32.6% -65.0%
5 GLAS Glass House Brands -28.5% n/a
6 QNC Quantum eMotion -27.1% n/a
7 EMAT Evolution Metals & Technologies -23.5% n/a
8 OCUL Ocular Therapeutix -23.3% -36.8%
9 ADV Advantage Solutions -22.6% n/a
10 VKTX Viking Therapeutics -21.7% -7.3%

 
Movers Over The Last Month

And over the last 21 trading days, the strongest and weakest names in the Trefis coverage universe:
 
Winners
 

# Ticker Company Name 1-M
Returns
YTD
Returns
1 SECZ Securitize 125.9% n/a
2 BNC CEA Industries 90.6% -8.3%
3 DNA Ginkgo Bioworks 88.4% 54.4%
4 IOVA Iovance Biotherapeutics 81.4% 442.9%
5 SVIA Silvia 79.4% n/a
6 PACB Pacific Biosciences of California 74.9% 26.7%
7 SDGR Schrodinger 59.2% 73.7%
8 MNTK Montauk Renewables 58.7% 63.5%
9 VICR Vicor 54.0% 163.6%
10 BALY Ballys 53.1% -16.9%

 
Losers
 

# Ticker Company Name 1-M
Returns
YTD
Returns
1 ALMS Alumis -66.1% -24.3%
2 LQDA Liquidia -55.6% -12.3%
3 QURE uniQure -50.4% 1.0%
4 KDK Kodiak AI -49.2% -82.4%
5 FICO Fair Isaac -48.4% -65.0%
6 CTEV Claritev -46.8% -50.5%
7 METC Ramaco Resources -41.9% -54.1%
8 RARE Ultragenyx Pharmaceutical -40.4% -34.7%
9 CXM Sprinklr -39.7% -36.4%
10 ALHC Alignment Healthcare -39.1% -58.7%

 

The Tape Rewards Attention. It Punishes Reaction

Big daily moves pull hard at both greed and fear, and acting on either, day after day, is how most portfolios end up trailing the index they were trying to beat.

The Trefis High Quality (HQ) Portfolio is built for the opposite reflex: about 30 quality businesses screened for the fundamentals that survive volatile stretches, held with rules instead of reactions. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Read the movers daily; trade them rarely.